Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia.

Sanaa KhanKrishnan VpYamini KrishnanGazel SainulabdinSomdipa PalRincy MathewsDarshan KatariaKunal SehgalPurva KanvindeLashkari HarshaprasadMinnie BodhanwalaBharat AgarwalAmbreen PandrowalaPrashant Hiwarkar

Published in: HemaSphere (2024)

Keyphrases

acute lymphoblastic leukemia
allogeneic hematopoietic stem cell transplantation
randomized controlled trial
acute myeloid leukemia
risk factors
multiple myeloma
childhood cancer